ClinicalTrials.Veeva

Menu

Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use

University of Michigan logo

University of Michigan

Status

Active, not recruiting

Conditions

Venous Thromboembolism
Pulmonary Embolism
Atrial Fibrillation

Treatments

Behavioral: Existing-prescription notification to prescriber
Behavioral: New-prescription Alert
Behavioral: New-prescription Alert with referral option
Behavioral: Existing-prescription notification to pharmacist

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT05351749
HUM00207165
R18HS028562 (U.S. AHRQ Grant/Contract)

Details and patient eligibility

About

The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors.

Findings from this project will establish a framework for implementing prescriber-pharmacist collaboration for high risk medications, including anticoagulants

Full description

Please note that the 3rd and 4th outcome measures are conditional on the outcomes of the 1st and 2nd outcome measures respectively.

Please note that enrollment of 300 will provide sufficient power to study.

Enrollment

306 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Prescribers:

Inclusion Criteria:

  • Michigan Medicine provider with prescribing privileges
  • Providers in ambulatory care settings
  • Prescribe DOAC to patients 18 years and older

Exclusion Criteria:

  • Providers in inpatient settings
  • Providers who are members of the study team

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

306 participants in 4 patient groups

New-prescription Alert / Existing-prescription notification to prescriber
Experimental group
Treatment:
Behavioral: New-prescription Alert
Behavioral: Existing-prescription notification to prescriber
New-prescription Alert w/ referral option/ Existing-prescription notification to prescriber
Experimental group
Treatment:
Behavioral: New-prescription Alert with referral option
Behavioral: Existing-prescription notification to prescriber
New-prescription Alert/ Existing-prescription notification to pharmacist
Experimental group
Treatment:
Behavioral: Existing-prescription notification to pharmacist
Behavioral: New-prescription Alert
New-prescription Alert w/ referral option/ Existing-prescription notification to pharmacist
Experimental group
Treatment:
Behavioral: Existing-prescription notification to pharmacist
Behavioral: New-prescription Alert with referral option

Trial contacts and locations

1

Loading...

Central trial contact

Jake Seagull, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems